PATENT CLAIM ANALYSIS

Application Number: 16107936
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "04400A"]

Abstract:
This disclosure relates to methods and compositions for managing vascular conditions by targeting microRNA. In certain embodiments, the disclosure relates to antisense, RNA interference, and blocking oligonucleotide therapeutic compositions and uses related thereto.

Claim (Index 13):
The method of  claim 10 , wherein the subject has type I or type II diabetes, impaired glucose tolerance, elevated serum C-reactive protein concentration, vitamin B6 deficiency, dietary iodine deficiency, hypothyroidism, hyperlipidemia, hypertension, or is older than 50 years old, or smokes cigarettes daily.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 96.0
- Lexical Diversity: 1.31034
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14433150', '13583963', '14561709', '15243604', '14474965']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7860514291063067
- 35 USC 102 Novelty (BERT): 0.519351802549803
- Combined Prediction Score: 0.7593814664506563
- Mean Citation Score: 272.43902
- Max Citation Score: 277.95663
- Similarity Product: 169.6635896523428

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test